Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft-versus-host disease after allogeneic transplantation-Reference-Cited by-同舟云学术

Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft-versus-host disease after allogeneic transplantation

Published:2005-08 Issue:3 Volume:130 Page:394-403
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Perez-Simon Jose A.,Diez-Campelo Maria,Martino Rodrigo,Brunet Salut,Urbano Alvaro,Caballero Maria D.,Leon Angel,Valcarcel David,Carreras Enric,del Canizo Maria C.,Lopez-Fidalgo Jesus,Sierra Jordi,San Miguel Jesus F.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2005.05614.x/fullpdf

Reference45 articles.

1. Development of a prognostic model for grading chronic graft-versus-host disease

2. Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter study

3. Long-Term Follow-Up of a Randomized Trial of Two Irradiation Regimens for Patients Receiving Allogeneic Marrow Transplants During First Remission of Acute Myeloid Leukemia

4. Mechanism for cotolerance in nonlethally conditioned mixed chimeras: negative selection of the Vbeta T-cell receptor repertoire by both host and donor bone marrow-derived cells

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of ADAMTS13 on graft‐versus‐host disease;Journal of Cellular and Molecular Medicine;2024-07

2. How does ocular graft‐versus‐host disease fit under the dry eye umbrella? A review;Clinical & Experimental Ophthalmology;2024-01-10

3. Reduced-Intensity Compared to Nonmyeloablative Conditioning in Patients with Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation;Transplantation and Cellular Therapy;2024-01

4. Extracorporeal Photopheresis as Graft-versus-Host Disease Prophylaxis: A Randomized Controlled Trial;Transplantation and Cellular Therapy;2023-06

5. Post‐transplant cyclophosphamide as sole GHVD prophylaxis after matched reduced‐intensity conditioning allotransplant;Clinical and Translational Medicine;2023-04